Quantitative sputum analysis: neuraminidase and tuberculosis

Area of Science:

• Pulmonary Medicine
• Biochemistry
• Microbiology

Background:

• Pulmonary tuberculosis (TB) diagnosis relies on sensitive screening methods.
• Mycobacterium tuberculosis infection triggers host responses, including macrophage activation.

Purpose of the Study:

• To evaluate sputum neuraminidase as a clinically sensitive screening test for pulmonary tuberculosis.
• To assess the correlation between sputum neuraminidase levels and TB diagnosis.

Main Methods:

• Quantification of sputum lysosomal enzymes, specifically neuraminidase, from mycobacterium-infected macrophages.
• Utilized fixed-volume samplers and variable volume micropipets for enzyme measurement.

Main Results:

• A high correlation (0.995) was observed between different measurement methods.
• Mean sputum neuraminidase levels were significantly higher in tuberculous patients (15.08 mU/mL) compared to non-tuberculous individuals (0.90 mU/mL) (P<0.001).
• Sputum neuraminidase levels above 1.0 mU/mL correctly identified 92.0% of TB patients.

Conclusions:

• Calibrated samplers enable reliable sputum enzyme quantification.
• Sputum neuraminidase levels exceeding 1.0 mU/mL are strongly associated with Mycobacterium tuberculosis infection.
• Sputum neuraminidase measurement presents a valuable screening tool for identifying samples for further, more specific diagnostic tests.